Vixtimotamab

Tax included
Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML).
MedChemExpress 
HY-P99958

Data sheet

Size
Multiple sizes
Reactivity
Others